Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Breitner

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Alzheimer'S Disease : JAD|December 28, 2017
Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's DiseaseKyoko Konishi, Ridha Joober, Judes Poirier, et al.
Journal of Alzheimer'S Disease : JAD|June 1, 2020
APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI DatasetSheida Rabipour, Sricharana Rajagopal, Elsa Yu, et al.
Journal of Alzheimer'S Disease : JAD|April 18, 2018
Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease PathogenesisPierre-François Meyer, Melissa Savard, Judes Poirier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 9, 2019
Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammationJustin Miron, Cynthia Picard, Marie-Élyse Lafaille-Magnan, et al.
Human Brain Mapping|November 23, 2017
Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's diseaseChristine L Tardif, Gabriel A Devenyi, Robert S C Amaral, et al.
International Journal of Geriatric Psychiatry|May 18, 2013
Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County StudyMartin Steinberg, Kyle Hess, Chris Corcoran, et al.
Neurology|April 7, 2019
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer diseasePierre-François Meyer, Jennifer Tremblay-Mercier, Jeannie Leoutsakos, et al.
Neurology|February 5, 2020
Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adultsMelissa McSweeney, Alexa Pichet Binette, Pierre-François Meyer, et al.
Data in Brief|December 8, 2016
A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairmentAngela Tam, Christian Dansereau, AmanPreet Badhwar, et al.
IEEE Transactions on Medical Imaging|April 20, 2017
Validation of a Regression Technique for Segmentation of White Matter Hyperintensities in Alzheimer's DiseaseMahsa Dadar, Tharick A Pascoal, Sarinporn Manitsirikul, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Alzheimer'S Disease : JAD|December 28, 2017
Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's DiseaseKyoko Konishi, Ridha Joober, Judes Poirier, et al.
Journal of Alzheimer'S Disease : JAD|June 1, 2020
APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI DatasetSheida Rabipour, Sricharana Rajagopal, Elsa Yu, et al.
Journal of Alzheimer'S Disease : JAD|April 18, 2018
Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease PathogenesisPierre-François Meyer, Melissa Savard, Judes Poirier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 9, 2019
Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammationJustin Miron, Cynthia Picard, Marie-Élyse Lafaille-Magnan, et al.
Human Brain Mapping|November 23, 2017
Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's diseaseChristine L Tardif, Gabriel A Devenyi, Robert S C Amaral, et al.
International Journal of Geriatric Psychiatry|May 18, 2013
Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County StudyMartin Steinberg, Kyle Hess, Chris Corcoran, et al.
Neurology|April 7, 2019
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer diseasePierre-François Meyer, Jennifer Tremblay-Mercier, Jeannie Leoutsakos, et al.
Neurology|February 5, 2020
Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adultsMelissa McSweeney, Alexa Pichet Binette, Pierre-François Meyer, et al.
Data in Brief|December 8, 2016
A dataset of multiresolution functional brain parcellations in an elderly population with no or mild cognitive impairmentAngela Tam, Christian Dansereau, AmanPreet Badhwar, et al.
IEEE Transactions on Medical Imaging|April 20, 2017
Validation of a Regression Technique for Segmentation of White Matter Hyperintensities in Alzheimer's DiseaseMahsa Dadar, Tharick A Pascoal, Sarinporn Manitsirikul, et al.
Pageof 4